Camelot Event-Driven Advisors LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.41M Buy
+73,456
New +$4.63M 2.13% 16

Other funds holding BMRN

Camelot Event-Driven Advisors LLC's BMRN Position: Q3 2026 in Review

Camelot Event-Driven Advisors LLC opened a new position in BioMarin Pharmaceuticals (BMRN) in Q3 2026: 73,456 shares worth $4.41M. The stake represents 2.13% of the portfolio and ranks #16 among its holdings.

559 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • Camelot Event-Driven Advisors LLC held 73,456 shares of BioMarin Pharmaceuticals worth $4.41M as of Q3 2026.
  • BioMarin Pharmaceuticals was a new Camelot Event-Driven Advisors LLC position in Q3 2026.
  • BioMarin Pharmaceuticals made up 2.13% of Camelot Event-Driven Advisors LLC's portfolio in Q3 2026, its #16 holding.
  • 559 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on Camelot Event-Driven Advisors LLC's 13F filing for Q3 2026, filed 16 Nov 2026.